We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Estimation of Cardiac Output in Neonatal ICU Using an Ultrasound Dilution Technique (CH)

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01610622
First Posted: June 4, 2012
Last Update Posted: May 27, 2016
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborator:
National Heart, Lung, and Blood Institute (NHLBI)
Information provided by (Responsible Party):
Transonic Systems Inc.
  Purpose
Presently there is no apparatus, clinically available, for routine determination of cardiac output (CO) in children. The goal of this research is to develop new technology that will help determine CO in neonates.

Condition Intervention
Neonatal Intensive Care Device: COstatus cardiac output measurement with isotonic saline

Study Type: Observational
Study Design: Time Perspective: Prospective
Official Title: Estimation of Cardiac Output in Neonatal ICU Using an Ultrasound Dilution Technique

Further study details as provided by Transonic Systems Inc.:

Enrollment: 7
Study Start Date: March 2012
Study Completion Date: May 2013
Primary Completion Date: May 2013 (Final data collection date for primary outcome measure)
Intervention Details:
    Device: COstatus cardiac output measurement with isotonic saline

    Isotonic saline, which is the indicator, is injected to obtain COstatus cardiac output measurements.

    No other interventions are made for the purpose of the study.

  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   up to 1 Month   (Child)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Patients from Neonatal Intensive Care Unit
Criteria

Inclusion Criteria:

  • All neonatal patients cared for in our ICU with umbilical venous and arterial catheters simultaneously in place for their care, will be eligible.

Exclusion Criteria:

  • Patients would be excluded if the family/guardian denied permission or if the attending physician felt the patient was not stable.
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01610622


Locations
United States, New York
Crouse Hospital
Syracuse, New York, United States, 13210
Sponsors and Collaborators
Transonic Systems Inc.
National Heart, Lung, and Blood Institute (NHLBI)
Investigators
Principal Investigator: Bonnie Marr, MD Crouse Hospital
  More Information

Responsible Party: Transonic Systems Inc.
ClinicalTrials.gov Identifier: NCT01610622     History of Changes
Other Study ID Numbers: TSI-C-COSTATUS-4A-H
R44HL061994 ( U.S. NIH Grant/Contract )
First Submitted: May 30, 2012
First Posted: June 4, 2012
Last Update Posted: May 27, 2016
Last Verified: May 2016

Keywords provided by Transonic Systems Inc.:
Cardiac Output
Blood volumes
Neonates